tuftsin has been researched along with Cancer of Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babcock, GF; Nishioka, K; Noyes, RD; Phillips, JH | 1 |
| Ben-Baruch, N; Ben-Yosef, R; Biran, S; Catane, R; Gez, E; Sulkes, A; Uziely, B; Warner, E | 1 |
| Babcock, GF; Banks, RA; Kazazi, F; Nishioka, K | 1 |
1 trial(s) available for tuftsin and Cancer of Lung
| Article | Year |
|---|---|
Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lung.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Middle Aged; Tuftsin | 1987 |
2 other study(ies) available for tuftsin and Cancer of Lung
| Article | Year |
|---|---|
Antitumor effect of tuftsin.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; Immunoglobulin Fragments; Killer Cells, Natural; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Tuftsin | 1981 |
Effect of tuftsin on in vivo development of 3-methylcholanthrene-induced primary fibrosarcoma and Lewis lung carcinoma in mice.
Topics: Animals; Carcinoma; Cell Line; Fibrosarcoma; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred C57BL; Tuftsin | 1985 |